May 12, 2022 by Kody KesterThese High-Yield Dividend Stocks Are Growing at Blazing SpeedsThese two stocks can provide income investors with dividend yields that are double what the broader market is offering.
May 11, 2022 by Kody KesterThis Dividend King Just Joined an Exclusive Club -- Here's Why the Stock Is a BuyJohnson & Johnson recently became part of the group that has raised its dividends for six straight decades.
May 11, 2022 by Kody KesterIs This Fast-Growing Dividend Stock a Buy?Anthem continues to generate double-digit revenue and earnings growth.
May 7, 2022 by Kody KesterBristol-Myers Squibb Snags Another Approval for This Mega-Blockbuster DrugThe EC has approved its cancer drug Opdivo, together with chemotherapy, to treat esophageal cancer.
May 7, 2022 by Kody KesterThe Best Real Estate Stock for a Lifetime of Passive IncomeThis Dividend Aristocrat can provide income investors with a safe and market-crushing 4.3% dividend yield.
May 6, 2022 by Kody Kester3 Reasons to Buy This Dominant Dividend StockBlackRock's market-beating 3.1% dividend yield is just the start of what makes it an intriguing dividend stock.
May 6, 2022 by Kody Kester3 Top Biotech Stocks to Buy Right NowThese three pharma stocks each pay market-beating dividends to shareholders.
May 5, 2022 by Kody Kester3 Top Healthcare Stocks to Buy for MayThese three stocks are leaders in their respective areas of the healthcare sector.
May 5, 2022 by Kody KesterShould You Buy This Unstoppable Healthcare Stock?This health insurer is a big fish in a large pond.
May 4, 2022 by Kody Kester2 Income REITs to Buy in MayBoth of these real estate investment trusts offer investors above-average dividend yields.
May 1, 2022 by Kody Kester3 Reasons to Consider Buying This Overlooked Medical Device StockThe Nasdaq's sell-off looks to have given investors a buying opportunity in this little-known medical device stock.
Apr 29, 2022 by Kody KesterWhat This Regulatory News Could Mean for MerckMerck's Keytruda-chemotherapy combo could soon be approved to treat cervical cancer in the European Union.
Apr 28, 2022 by Kody Kester3 Reasons to Buy This Retailer After Its Dividend BoostRoss Stores recently announced that it would be returning more capital to shareholders.
Apr 28, 2022 by Kody KesterCould This FDA Approval Be a Boost for Merck?Merck's mega-blockbuster Keytruda was given the nod to treat patients with a type of endometrial cancer in the U.S.
Apr 28, 2022 by Kody KesterShould You Buy This Dividend Growth Stock?Last month, TJX Companies boosted its quarterly dividend by a staggering 13.5%.
Apr 27, 2022 by Kody Kester3 Reasons Why Innovative Industrial Properties Is Inflation-ResistantThe cannabis real estate investment trust offers much more to investors than its market-crushing 4.6% dividend yield.
Apr 27, 2022 by Kody KesterWhy I'll Never Sell American TowerThe communications infrastructure real estate investment trust will become even more indispensable in the years to come.
Apr 25, 2022 by Kody Kester2 Top Biotech Stocks to Buy Right NowThe encouraging pharmaceutical industry outlook bodes well for both of these blue-chip pharma stocks.
Apr 25, 2022 by Kody KesterHere's 1 High-Yield Dividend Stock to Consider BuyingBig pharma company Novartis pays big dividends -- but there are other reasons for investors to buy its stock.
Apr 22, 2022 by Kody KesterIs This Value Stock a Buy?Humana is among the largest health insurers in the world.
